PURA and myelodysplastic syndrome: Most recently, by analyzing clinical data of patients, another study also revealed that the deletion of the PURA gene in MDS was one of the anti-drivers for the pathogenesis of MDS, and was also associated with the clinical phenotype and poor prognosis of MDS patients (Adema et al. 2022).